DaVita Inc
DVA
查看详细走势图
113.985USD
-0.425-0.37%
收盘 12/26, 16:00（美东）报价延迟15分钟
8.09B总市值
11.49市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-0.37%
5天
-1.05%
1月
-5.09%
6月
-19.54%
今年开始到现在
-23.78%
1年
-26.13%
查看详细走势图
TradingKey DaVita Inc股票评分
单位: USD 更新时间: 2025-12-26操作建议
DaVita Inc当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在医疗服务供应商行业排名41/78位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价138.59。中期看，股价处于下降通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
DaVita Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
10
位分析师
持有
评级
138.587
目标均价
+18.40%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
DaVita Inc亮点
亮点风险
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
利润高增长
公司净利润处于行业前列，最新年度总收入12.82B美元
估值低估
公司最新PE估值11.49，处于3年历史低位
机构加仓
最新机构持股36.29M股，环比增加0.04%
加拿大丰业银行分红基金持仓
明星投资者加拿大丰业银行分红基金持仓，最新持仓市值4.93K
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
DaVita Inc简介
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
公司代码DVA
公司DaVita Inc
CEORodriguez (Javier J)
网址https://www.davita.com/
常见问题
DaVita Inc(DVA)的当前股价是多少？
DaVita Inc(DVA)的当前股价是 113.985。
DaVita Inc的股票代码是什么？
DaVita Inc的股票代码是DVA。
DaVita Inc股票的52周最高点是多少？
DaVita Inc股票的52周最高点是179.600。
DaVita Inc股票的52周最低点是多少？
DaVita Inc股票的52周最低点是113.120。
DaVita Inc的市值是多少？
DaVita Inc的市值是8.09B。
DaVita Inc的净利润是多少？
DaVita Inc的净利润为936.34M。
现在DaVita Inc(DVA)的股票是买入、持有还是卖出？
根据分析师评级，DaVita Inc(DVA)的总体评级为持有，目标价格为138.587。
DaVita Inc(DVA)股票的每股收益（EPS TTM）是多少
DaVita Inc(DVA)股票的每股收益（EPS TTM）是9.921。
相关品种
+1.30%
+0.29%
+0.03%
+0.11%
-0.49%
-0.05%
-0.13%
-0.75%
+0.67%
+0.59%
+1.91%
+0.59%
+0.34%
+0.09%
+0.04%
+0.64%
+0.26%
+0.05%
+0.26%
+0.67%
